Objective: To evaluate long-term ipsilateral hearing preservation in patients who underwent cochlear implantation for the combined electric acoustic stimulation of the auditory system. Methods: This was a prospective observational study conducted at a tertiary referral center. Twenty-three subjects were implanted with the MED-EL C40+ standard or C40+ medium electrode using an atraumatic surgical protocol via an anterior-inferior cochleostomy approach. The desired insertion depth was 18–24 mm or 360°. All patients showed significant low-frequency hearing prior to surgery and monosyllabic word scores did not exceed 40% in the best aided condition. Pure-tone audiometry was performed prior to implantation and at distinct intervals after surgery. Results: Nine patients (39.1%) showed complete pure-tone audiometric hearing preservation (0–10 dB) over an average of 29 months. Seven subjects (30.4%) showed partial preservation of residual hearing (hearing loss 15–40 dB) until an average of 25 months. Delayed loss of residual hearing was observed in 5 cases (21.7%) and 2 patients (8.6%) completely lost residual hearing during or immediately after surgery. Freiburger Monosyllabic word understanding scores in a group of patients with complete hearing preservation increased from 13.1% preoperatively to 75% in the electric acoustic stimulation condition. Conclusion: This study documents that complete and partial preservation of ipsilateral hearing after cochlear implantation can be achieved in about 70% of cases over an average period of 27.25 months when using 360° electrode insertions.

Keywords:
Cochlear implants, Acoustic stimulation, Electric stimulation, Hearing loss, Electric acoustic stimulation, Hearing preservation
1.
Adunka O, Gstoettner W, Hambek M, et al: Preservation of basal inner ear structures in cochlear implantation. ORL J Otorhinolaryngol Relat Spec 2004a;66:306–312.
2.
Adunka O, Kiefer J, Unkelbach MH, et al: Development and evaluation of an improved cochlear implant electrode design for electric acoustic stimulation. Laryngoscope 2004b; 114:1237–1241.
3.
Adunka O, Pillsbury CH, Kiefer J: Combining perimodiolar electrode placement and atraumatic insertion properties in cochlear implantation – fact or fantasy? Acta Otolaryngol, in press.
4.
Adunka O, Unkelbach MH, Mack M, et al: Cochlear implantation via the round window membrane minimizes trauma to cochlear structures: a histologically controlled insertion study. Acta Otolaryngol 2004c;124:807–812.
5.
Adunka O, Unkelbach MH, Mack MG, et al: Predicting basal cochlear length for electric-acoustic stimulation. Arch Otolaryngol Head Neck Surg 2005;131:488–492.
6.
Aschendorff A, Klenzner T, Richter B, et al: Evaluation of the HiFocus electrode array with positioner in human temporal bones. J Laryngol Otol 2003;117:527–531.
7.
Briggs RJ, Tykocinski M, Stidham K, et al: Cochleostomy site: implications for electrode placement and hearing preservation. Acta Otolaryngol 2005;125:870–876.
8.
Eshraghi AA, Polak M, He J, et al: Pattern of hearing loss in a rat model of cochlear implantation trauma. Otol Neurotol 2005;26:442–447; discussion 447.
9.
Gantz BJ, Turner CW: Combining acoustic and electrical hearing. Laryngoscope 2003;113:1726–1730.
10.
Gantz BJ, Turner C, Gfeller KE, et al: Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngoscope 2005;115:796–802.
11.
Greenwood DD: A cochlear frequency-position function for several species – 29 years later. J Acoust Soc Am 1990;87:2592–2605.
12.
Greenwood DD: Comparing octaves, frequency ranges, and cochlear-map curvature across species. Hear Res 1996;94:157–162.
13.
Gstoettner WK, Adunka O, Franz P, et al: Perimodiolar electrodes in cochlear implant surgery. Acta Otolaryngol 2001;121:216–219.
14.
Gstoettner W, Kiefer J, Baumgartner WD, et al: Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol 2004;124:348–352.
15.
Hodges AV, Schloffman J, Balkany T: Conservation of residual hearing with cochlear implantation. Am J Otol 1997;18:179–183.
16.
James C, Albegger K, Battmer R, et al: Preservation of residual hearing with cochlear implantation: how and why. Acta Otolaryngol 2005;125:481–491.
17.
Kiefer J, Gstoettner W, Baumgartner W, et al: Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272–280.
18.
Kiefer J, Pok M, Adunka O, et al: Combined electric and acoustic stimulation of the auditory system: results of a clinical study. Audiol Neurootol 2005;10:134–144.
19.
Lehnhardt E: Intracochlear placement of cochlear implant electrodes in soft surgery technique (in German). HNO 1993;41:356–359.
20.
Paasche G, Bogel L, Leinung M, et al: Substance distribution in a cochlea model using different pump rates for cochlear implant drug delivery electrode prototypes. Hear Res 2006;212:74–82.
21.
Richter B, Jaekel K, Aschendorff A, et al: Cochlear structures after implantation of a perimodiolar electrode array. Laryngoscope 2001;111:837–843.
22.
Scarpidis U, Madnani D, Shoemaker C, et al: Arrest of apoptosis in auditory neurons: implications for sensorineural preservation in cochlear implantation. Otol Neurotol 2003;24:409–417.
23.
Skarzynski H, Lorens A, Piotrowska A: A new method of partial deafness treatment. Med Sci Monit 2003;9:CS20–CS24.
24.
Staecker H, Brough DE, Praetorius M, et al: Drug delivery to the inner ear using gene therapy. Otolaryngol Clin North Am 2004;37:1091–1108.
25.
von Ilberg C, Kiefer J, Tillein J, et al: Electric-acoustic stimulation of the auditory system. New technology for severe hearing loss. ORL J Otorhinolaryngol Relat Spec 1999;61:334–340.
26.
Zrunek M, Lischka M, Hochmair-Desoyer I, et al: Dimensions of the scala tympani in relation to the diameters of multichannel electrodes. Arch Otorhinolaryngol 1980;229:159–165.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.